Novo’s CagriSema achieves 25% weight loss in women, driven by younger patients
Novo has reported 25% weight loss in women taking CagriSema, largely replicating data on Eli Lilly’s rival drug in post…
Novo has reported 25% weight loss in women taking CagriSema, largely replicating data on Eli Lilly’s rival drug in post…